Relationship between salivary melatonin and severity of periodontal disease

被引:51
作者
Cutando, Antonio
Galindo, Pablo
Gomez-Moreno, Gerardo
Arana, Carlos
Bolanos, Jorge
Acuna-Castroviejo, Dario
Wang, Hom-Lay
机构
[1] Univ Granada, Sch Dent, Dept Special Care Dent, Granada, Spain
[2] Univ Granada, Sch Dent, Dept Oral Surg, Granada, Spain
[3] Univ Granada, Fac Lib Sci & Documentat, Stat & Operat Res Dept, Granada, Spain
[4] Univ Granada, Inst Biotechnol, Dept Physiol, Granada, Spain
[5] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA
关键词
melatonin; periodontal diseases; periodontal index; plasma; saliva;
D O I
10.1902/jop.2006.050287
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: Melatonin possesses antioxidant, free-radical scavenging, and immunoenhancing properties that promote fibroblast activity and bone regeneration. The aim of this study was to examine the possible links between salivary melatonin levels and the severity of periodontal disease using the community periodontal index (CPI). Methods: Thirty-seven patients with different degrees of periodontal disease were studied. Salivary and plasma melatonin levels (by radioimmunoassay), salivary/plasma melatonin ratio, and CPI status were collected for each patient. The Spearman correlation coefficient was used to analyze relationships among variables. Results: Data showed a significant correlation between CPI and salivary/plasma melatonin ratios. When saliva volume was controlled for, a significant correlation (P < 0.05) was found between lower salivary melatonin and a worse CPI. This finding suggests that melatonin may act as a protector against free radicals produced by inflammatory periodontal diseases. Conclusions: Salivary melatonin levels varied according to the degree of periodontal disease. As the degree of periodontal disease increased, the salivary melatonin level decreased, indicating that melatonin may act to protect the body from external bacterial insults. Therefore, melatonin may be potentially valuable in the treatment of periodontal diseases, although further research is required to validate this hypothesis.
引用
收藏
页码:1533 / 1538
页数:6
相关论文
共 33 条
[1]  
Acuna Castroviejo Dario, 2002, Curr Top Med Chem, V2, P133
[2]   MELATONIN RADIOIMMUNOASSAY [J].
ARENDT, J ;
PAUNIER, L ;
SIZONENKO, PC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1975, 40 (02) :347-350
[3]   Oxidative injury and inflammatory periodontal diseases: The challenge of antioxidants to free radicals and reactive oxygen species [J].
Battino, M ;
Bullon, P ;
Wilson, M ;
Newman, H .
CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 1999, 10 (04) :458-476
[4]   Osteoclast differentiation and activation [J].
Boyle, WJ ;
Simonet, WS ;
Lacey, DL .
NATURE, 2003, 423 (6937) :337-342
[5]   Melatonin effects on bone: experimental facts and clinical perspectives [J].
Cardinali, DP ;
Ladizesky, MG ;
Boggio, V ;
Cutrera, RA ;
Mautalen, C .
JOURNAL OF PINEAL RESEARCH, 2003, 34 (02) :81-87
[6]   Relationship between salivary melatonin levels and periodontal status in diabetic patients [J].
Cutando, A ;
Gómez-Moreno, G ;
Villalba, J ;
Ferrera, MJ ;
Escames, G ;
Acuña-Castroviejo, D .
JOURNAL OF PINEAL RESEARCH, 2003, 35 (04) :239-244
[7]   Correlation between nuclear melatonin receptor expression and enhanced cytokine production in human lymphocytic and monocytic cell lines [J].
García-Mauriño, S ;
Pozo, D ;
Calvo, JR ;
Guerrero, JM .
JOURNAL OF PINEAL RESEARCH, 2000, 29 (03) :129-137
[8]   Involvement of nuclear binding sites for melatonin in the regulation of IL-2 and IL-6 production by human blood mononuclear cells [J].
Garcia-Mauriño, S ;
Gonzalez-Haba, MG ;
Calvo, JR ;
Goberna, R ;
Guerrero, JM .
JOURNAL OF NEUROIMMUNOLOGY, 1998, 92 (1-2) :76-84
[9]  
Guerrero JM, 2000, ANN NY ACAD SCI, V917, P397
[10]   Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation [J].
Koyama, H ;
Nakade, O ;
Takada, Y ;
Kaku, T ;
Lau, KHW .
JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (07) :1219-1229